Paper36029239
Risk of Pancreatic Cancer in the Long-Term Prospective Follow-Up of Familial Pancreatic Cancer Kindreds.
Porter N and 11 others. J Natl Cancer Inst, 2022. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. Risk of Pancreatic Cancer in the Long-Term Prospective Follow-Up of Familial Pancreatic Cancer Kindreds. Papers, record 36029239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36029239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Predisposition to Disease | Major topic |
| Pancreatic Neoplasms | Major topic |
| Humans | |
| Aged | |
| Prospective Studies | |
| Retrospective Studies | |
| Risk Factors | |
| Carcinoma |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 CA247886 | NCI NIH HHS | United States | P01CA247886 | PubMed and NIH | NIH RePORTER |
| P50 CA062924 | NCI NIH HHS | United States | P50CA062924 | PubMed and NIH | NIH RePORTER |
| R01 CA197296 | NCI NIH HHS | United States | R01CA197296 | PubMed | NIH RePORTER |
| P50 CA62924 | NCI NIH HHS | United States | P50CA062924 | PubMed and NIH | NIH RePORTER |
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20068195 | Importance of age of onset in pancreatic cancer kindreds. | J Natl Cancer Inst | 2010 | https://conductscience.org/library/papers/20068195 | PubMed |
| 2 | 19264984 | Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. | Science | 2009 | https://conductscience.org/library/papers/19264984 | PubMed |
| 3 | 27114589 | Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers. | J Clin Oncol | 2016 | https://conductscience.org/library/papers/27114589 | PubMed |
| 4 | 20049842 | Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). | Int J Cancer | 2010 | https://conductscience.org/library/papers/20049842 | PubMed |
| 5 | 10891514 | Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. | N Engl J Med | 2000 | https://conductscience.org/library/papers/10891514 | PubMed |
| 6 | 31015203 | Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study. | Cancer Epidemiol Biomarkers Prev | 2019 | https://conductscience.org/library/papers/31015203 | PubMed |
| 7 | 22104574 | Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). | Ann Oncol | 2012 | https://conductscience.org/library/papers/22104574 | PubMed |
| 8 | 31197699 | Surgical Outcomes After Pancreatic Resection of Screening-Detected Lesions in Individuals at High Risk for Developing Pancreatic Cancer. | J Gastrointest Surg | 2020 | https://conductscience.org/library/papers/31197699 | PubMed |
| 9 | 7666916 | Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. | N Engl J Med | 1995 | https://conductscience.org/library/papers/7666916 | PubMed |
| 10 | 11135318 | Risk factors for pancreatic cancer: a case-control study based on direct interviews. | Teratog Carcinog Mutagen | 2001 | https://conductscience.org/library/papers/11135318 | PubMed |
| 11 | 22585167 | ATM mutations in patients with hereditary pancreatic cancer. | Cancer Discov | 2012 | https://conductscience.org/library/papers/22585167 | PubMed |
| 12 | 28767289 | Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. | J Clin Oncol | 2017 | https://conductscience.org/library/papers/28767289 | PubMed |
| 13 | 28874546 | Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28874546 | PubMed |
| 14 | 15059921 | Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. | Cancer Res | 2004 | https://conductscience.org/library/papers/15059921 | PubMed |
| 15 | 29422604 | Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. | Nat Commun | 2018 | https://conductscience.org/library/papers/29422604 | PubMed |
| 16 | 16614112 | Pancreatic cancer genetic epidemiology consortium. | Cancer Epidemiol Biomarkers Prev | 2006 | https://conductscience.org/library/papers/16614112 | PubMed |
| 17 | 35020204 | Cancer statistics, 2022. | CA Cancer J Clin | 2022 | https://conductscience.org/library/papers/35020204 | PubMed |
| 18 | 27222437 | Validity of self-reported family history of cancer: A systematic literature review on selected cancers. | Int J Cancer | 2016 | https://conductscience.org/library/papers/27222437 | PubMed |
| 19 | 31386141 | Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement. | JAMA | 2019 | https://conductscience.org/library/papers/31386141 | PubMed |
| 20 | 19861671 | Risk of pancreatic cancer in families with Lynch syndrome. | JAMA | 2009 | https://conductscience.org/library/papers/19861671 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42897094 | Diabetes Among Finnish Pancreatic Cancer Patients: Prevalence, Time Interval Between Diabetes and Cancer Diagnosis, and Overall Survival. | Cancer Med | 2026 | https://conductscience.org/library/papers/42897094 | PubMed |
| 42557274 | Progress, challenges, and future directions of pancreatic cancer surveillance in high-risk populations. | Commun Med (Lond) | 2026 | https://conductscience.org/library/papers/42557274 | PubMed |
| 42511746 | Hereditary Pancreatic Cancer: Genetic Risk, Surveillance Strategies, and Therapeutic Implications. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511746 | PubMed |
| 42382372 | Duodenal Fluid Microbiome Diversity and Pancreatic Cyst Status Among Patients Undergoing Pancreatic Surveillance. | Gastro Hep Adv | 2026 | https://conductscience.org/library/papers/42382372 | PubMed |
| 42098138 | Pancreatic cancer. | Nat Rev Dis Primers | 2026 | https://conductscience.org/library/papers/42098138 | PubMed |
| 42007212 | Catching pancreatic cancer early: Are we there yet? | J Natl Cancer Cent | 2026 | https://conductscience.org/library/papers/42007212 | PubMed |
| 41848926 | Factors affecting compliance with pancreas surveillance in patients with familial/genetic risk. | Fam Cancer | 2026 | https://conductscience.org/library/papers/41848926 | PubMed |
| 41402815 | Familial risk of pancreatic cancer and interaction with hyperglycemia, smoking, and obesity among first-degree relatives. | BMC Cancer | 2025 | https://conductscience.org/library/papers/41402815 | PubMed |
| 40786205 | Pancreatic cancer: a persistently challenging prognosis - a single center three-year retrospective study. | Med Pharm Rep | 2025 | https://conductscience.org/library/papers/40786205 | PubMed |
| 40671101 | Metabolic syndrome as a prognostic factor in advanced pancreatic cancer: a predictive model and chemotherapy evaluation. | World J Surg Oncol | 2025 | https://conductscience.org/library/papers/40671101 | PubMed |
| 40591568 | Rising burden of pancreatic cancer in China: Trends, drivers, and future projections. | PLoS One | 2025 | https://conductscience.org/library/papers/40591568 | PubMed |
| 39809756 | Digestive cancers: mechanisms, therapeutics and management. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/39809756 | PubMed |
| 39031472 | Pancreatic cancer screening is effective in individuals at risk with predisposing germline gene variants, but not in gene variant-negative familial pancreatic cancer families. | United European Gastroenterol J | 2024 | https://conductscience.org/library/papers/39031472 | PubMed |
| 38869494 | Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk. | Cancer Epidemiol Biomarkers Prev | 2024 | https://conductscience.org/library/papers/38869494 | PubMed |
| 38780705 | The best linear unbiased prediction (BLUP) method as a tool to estimate the lifetime risk of pancreatic ductal adenocarcinoma in high-risk individuals with no known pathogenic germline variants. | Fam Cancer | 2024 | https://conductscience.org/library/papers/38780705 | PubMed |
| 38662265 | The role of biomarkers in the early detection of pancreatic cancer. | Fam Cancer | 2024 | https://conductscience.org/library/papers/38662265 | PubMed |
| 38609521 | Understanding familial risk of pancreatic ductal adenocarcinoma. | Fam Cancer | 2024 | https://conductscience.org/library/papers/38609521 | PubMed |
| 38573398 | Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC). | Fam Cancer | 2024 | https://conductscience.org/library/papers/38573398 | PubMed |
| 38319536 | Precursor lesions in familial and hereditary pancreatic cancer. | Fam Cancer | 2024 | https://conductscience.org/library/papers/38319536 | PubMed |
| 38007948 | A pancreatic cancer risk prediction model (Prism) developed and validated on large-scale US clinical data. | EBioMedicine | 2023 | https://conductscience.org/library/papers/38007948 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36029239
GET https://conductscience.org/api/papers/v1/36029239/references?page=2